tetano
Editor, Senior Moderator
J Med Virol
. 2020 Sep 8.
doi: 10.1002/jmv.26495. Online ahead of print.
Seroconversion against SARS-CoV-2 occurred after the recovery in patients with COVID-19
Shinya Yamamoto[SUP] 1 [/SUP], Makoto Saito[SUP] 1 [/SUP], Etsuko Nagai[SUP] 1 [/SUP], Keiko Toriuchi[SUP] 1 [/SUP], Hiroyuki Nagai[SUP] 1 [/SUP], Hiroshi Yotsuyanagi[SUP] 1 [/SUP], Yu Nakagama[SUP] 2 [/SUP], Yasutoshi Kido[SUP] 2 [/SUP], Eisuke Adachi[SUP] 1 [/SUP]
Affiliations
Abstract
Little is known about the protective immunity for coronavirus disease 2019 (COVID-19) while the demand for COVID-19 serology tests is increasing. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
. 2020 Sep 8.
doi: 10.1002/jmv.26495. Online ahead of print.
Seroconversion against SARS-CoV-2 occurred after the recovery in patients with COVID-19
Shinya Yamamoto[SUP] 1 [/SUP], Makoto Saito[SUP] 1 [/SUP], Etsuko Nagai[SUP] 1 [/SUP], Keiko Toriuchi[SUP] 1 [/SUP], Hiroyuki Nagai[SUP] 1 [/SUP], Hiroshi Yotsuyanagi[SUP] 1 [/SUP], Yu Nakagama[SUP] 2 [/SUP], Yasutoshi Kido[SUP] 2 [/SUP], Eisuke Adachi[SUP] 1 [/SUP]
Affiliations
- PMID: 32897566
- DOI: 10.1002/jmv.26495
Abstract
Little is known about the protective immunity for coronavirus disease 2019 (COVID-19) while the demand for COVID-19 serology tests is increasing. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.